23AndMe, Inc. · Class II · Cleared Jan 18, 2019
| K-number | K182784 |
| Device name | MUTYH-Associated Polyposis (MAP) |
| Applicant | 23AndMe, Inc. |
| Product code | QAZ |
| Device class | Class II |
| Decision date | Jan 18, 2019 |
| Decision | Substantially Equivalent |
| Regulation | 866.6090 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov